| Literature DB >> 31428622 |
Lucy A Coyne1, Sophia M Latham1, Susan Dawson2, Ian J Donald3, Richard B Pearson4, Rob F Smith2, Nicola J Williams1, Gina L Pinchbeck1.
Abstract
Increasing levels of antimicrobial resistance in human and veterinary medicine have raised concerns over the irresponsible use of antimicrobials. The role of administering antimicrobials in food producing animals most frequently falls to the farmer, therefore it is essential that their use of antimicrobials is both optimal and responsible. This study sought in-depth information on the drivers behind antimicrobial use behaviors and farmer attitudes to responsible use using a mixed-methodological approach. Initially, in-depth semi-structured interviews were conducted with a purposively selected sample of farmers (n = 22). A thematic analysis approach was taken to identify key themes from these qualitative data. The generalizability and variation of these themes was then tested on a larger randomly selected sample of pig farmers through a questionnaire study (n = 261). The influences behind antimicrobial use were complex with multiple drivers motivating decisions. There was no consensual opinion on what farming systems resulted in either a low or high antimicrobial requirement however, farmers reported that good management practices, low stocking densities, and a high health status were associated with low antimicrobial use. Farmers expressed desire to avoid the long-term use of in-feed antimicrobials, but identified barriers to discontinuing such behaviors, such as pig morbidity, mortality, and economic losses. The high cost of antimicrobials was described as a motivation toward seeking alternative methods of controlling disease to prophylactic use; however, this expense was balanced against the losses from an increased burden of disease. The high financial costs involved in pig production alongside the economic uncertainty of production and pressure from retailers, were identified as limiting the scope for improvements in pig accommodation and facilities which could reduce the antimicrobial requirements on farm. Long-term, sustainable and economically stable relationships between retailers and farmers may allow farmers to make necessary investments in improving management and housing in order to reduce antimicrobial use. Greater use and more widespread deployment of effective vaccinations were highlighted by farmers as being a feasible alternative to antimicrobial use in preventing disease.Entities:
Keywords: antibiotic; antimicrobial; antimicrobial resistance; antimicrobial use; behavior; farm animal; mixed-methods; prescribing
Year: 2019 PMID: 31428622 PMCID: PMC6688534 DOI: 10.3389/fvets.2019.00257
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Figure 1Questionnaire respondent opinion on the antimicrobial use requirements of different management features; low, moderate, or high.
Questionnaire respondent attitudes to the role of management and economic drivers in reducing the total amount of antimicrobials used in the UK pig industry.
| Eradicating swine dysentery from the UK | 11.0% (23) | 8.0% (17) | 81.0% (170) |
| Modernizing indoor pig accommodation | 4.4% (9) | 16.5% (34) | 79.1% (163) |
| More effective vaccines | 2.8% (6) | 6.1% (13) | 91.1% (195) |
| A wider range of vaccines | 3.9% (8) | 11.2% (23) | 84.9% (174) |
| De-population and re-populating low health status pig herds with higher health status stock | 2.5% (5) | 18.5% (37) | 79.0% (158) |
| Poor availability of highly skilled stock people | 69.9% (137) | 16.8% (33) | 13.3% (26) |
| Increased profitability of pig meat prices | 4.6% (10) | 26.9% (58) | 68.5% (148) |
| Increasing the cost of antimicrobials for farmers | 49.2% (103) | 40.7% (85) | 10.0% (21) |
| Decreasing the cost of antimicrobials for farmers | 19.3% (39) | 52.5% (106) | 28.2% (57) |
| Reducing imports from other countries with high antimicrobial use | 6.9% (15) | 12.0% (26) | 81.1% (176) |
| Prescription obtained from the vet and taken to a pharmacy to get antimicrobials (i.e., no longer sold by vet practices) | 61.8% (126) | 26.5% (54) | 11.8% (24) |
Frequency of reported disease conditions requiring antimicrobial treatment in different groups of pigs on farms in the year preceding the questionnaire study.
| Farrowing sows | 7.8% (9) | 7.0% (8) | 34.8% (40) | 50.4% (58) |
| Piglets | 56.5% (95) | 17.3% (29) | 0.0% (0) | 26.2% (44) |
| Feeding pigs | 22.6% (70) | 44.1% (137) | 0.6% (2) | 32.6% (101) |
| Dry sows | 0.0% (0) | 7.4% (9) | 17.4% (21) | 75.2% (91) |
Multivariable logistic regression analysis of respondent characteristics associated with requirements to use antimicrobials for different disease situations in different groups of pigs in the year preceding the questionnaire study.
| Number of sows on farm (log base 2 transformed) | Median | 105 | 320 | 1.3 | 1.1 | 1.4 | <0.001 |
| Number of sows on farm (log base 2 transformed) | Median | 40 | 285 | 1.5 | 1.3 | 1.8 | <0.001 |
| Closed herd | 127 (67.2%) | 62 (32.8%) | Ref | ||||
| 41 (58.6%) | 29 (41.4%) | 0.4 | 0.2 | 0.9 | 0.024 | ||
| Number of pigs (log base 2 transformed) | Median | 300 | 1,990 | 1.5 | 1.3 | 1.7 | <0.001 |
| Closed herd | No | 80 (42.3%) | 109 (57.7%) | Ref | |||
| Yes | 42 (60%) | 28 (40%) | 0.38 | 0.2 | 0.8 | 0.006 | |
| Enzootic Pneumonia vaccination status | 119 (50.6%) | 116 (49.4%) | Ref | ||||
| 5 (19.2%) | 21 (80.8%) | 3.1 | 1.1 | 9.0 | 0.037 | ||
| 21 (60%) | |||||||
| Flooring type | Outdoor | 33 (70.2%) | 14 (29.8%) | Ref | |||
| Straw | 35 (67.3%) | 17 (32.7%) | 5.2 | 2.1 | 13 | ||
| Slatted | 22 (33.3%) | 44 (66.7%) | 2.1 | 0.8 | 5.6 | 0.001 | |
| Sows PRRS vaccination status | No | 156 (72.9%) | 58 (27.1%) | Ref | |||
| Yes | 10 (21.3%) | 37 (78.7%) | 5 | 2 | 12.1 | <0.001 | |
LRT, likelihood ratio p-value.
Antimicrobials identified as HP-CIAs by UK pig farmers (n = 122) from a provided list of drugs including both generic and trade names.
| Amoxycillin (Amoxinsol, Stabox) | 45 (36.89%) |
| Apramycin (Apralan) | 12 (9.84%) |
| Ceftiofur (Excenel, Naxcel) | 30 (24.59%) |
| Colistin (Coliscour) | 6 (4.92%) |
| Florfenicol (Nuflor Swine) | 15 (12.30%) |
| Fluoroquinolones (Baytril, Marbocyl, Forcyl) | 52 (42.62%) |
| Lincomycin (Lincocin, Linco-spectin) | 18 (14.75%) |
| Penicillin (Duphapen, Ultrapen LA) | 50 (40.98%) |
| Spectinomycin (Spectam) | 5 (4.10%) |
| Tetracyclines (Terramycin, Engemycin, Aurofac) | 32 (26.23%) |
| Tiamulin (Denagard) | 5 (4.10%) |
| Tilmicosin (Pulmotil) | 4 (3.28%) |
| Trimethoprim sulfate (Trimediazine, Tribrissen, Norodine 24) | 9 (7.38%) |
| Tulathromycin (Draxxin) | 20 (16.39%) |
| Tylosin (Tylan) | 22 (18.03%) |
Shows HP-CIA classes according to the WHO 2012 definition (.
Questionnaire responses on the justification of antimicrobial use practices in UK pig production.
| Antimicrobial use for treatment of pigs with disease | 0.4% (1) | 2.1% (5) | 43.7% (104) | 53.8% (128) |
| Antimicrobial use for disease prevention | 18.9% (43) | 29.8% (68) | 44.3% (101) | 7.0% (16) |
| Antimicrobial use for growth promotion | 68.6% (151) | 23.6% (52) | 7.7% (17) | 0.0% (0) |
| The use of in-feed antimicrobial formulations in pigs | 17.6% (37) | 25.2% (53) | 48.6% (102) | 8.6% (18) |
Themes volunteered by questionnaire respondents as influencing the decision to continue or discontinue in-feed antimicrobials on their farm.
| Known disease issues in pigs | 21 | “ | High cost | 31 | “ |
| Veterinary advice | 21 | “ | Improvements in pig health | 19 | “ |
| To prevent a reduction in herd performance | 16 | “ | Discontinue use when clinical signs no longer present | 17 | “ |
| Prevention of disease is better than treating disease once clinical signs are apparent | 13 | “ | Veterinary advice is to discontinue in-feed antimicrobials | 15 | “ |
| Good efficacy | 11 | “ | Ineffective if used long term | 9 | “ |
| Disease problems occur if in-feed is withdrawn | 9 | “ | Concerns over antimicrobial resistance | 7 | “ |
| To maintain a high level of welfare | 8 | “ | Improvements in weather conditions | 6 | “ |
| Cost effective to continue with medication | 8 | “ | Personal concern over the ethics of the long-term use of in-feed antimicrobials | 5 | “ |
| To prevent high mortality rates | 6 | “ | Industry pressure to discontinue use of in-feed antimicrobials | 5 | “ |
| Respiratory disease problems | 5 | “ | |||
| Time of year when disease is common | 5 | “ | |||